Lyophilized Human Chorionic Gonadotropin 5 — Class II drug recall D-0158-2020
Terminated recall by Innoveix Pharmaceuticals Inc, reported 2019-11-06, distributed nationwide. Lack of Sterility Assurance.
| Recall number | D-0158-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Innoveix Pharmaceuticals Inc, Addison, TX, United States |
| Recall initiated | 2019-10-10 |
| Classified | 2019-10-28 |
| Reported by FDA | 2019-11-06 |
| Terminated | 2022-01-14 |
| Distributed | Nationwide (US) |
| Quantity | 413 vials |
| Reason classes | sterility |
| Lot numbers | 910, 915 |
| Expiration dates | 2020-02-07, 2020-03-12 |
Product
Lyophilized Human Chorionic Gonadotropin 5,000 USP Units For injection, Rx Only, Compounded by: Innoveix Addison, TX 75001 800-370-1910
Reason for recall
Lack of Sterility Assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0158-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.